In 51 patients who had uncommon EGFR mutations with comprehensive tumor genomic information, the multivariate analysis additionally identified that co-mutations of tumor-suppressor genes were also independently associated with poorer PFS (p = 0.001, HR 3.545, 95% CI 1.632–7.703) (Supplementary Table 6). This evidence concerns the gene EGFR and neoplasm.